SCOPE of Cardiometabolic Health in Asia-Pacific: Shaping Cardiometabolic Outcomes With Personalized Treatment Strategies and Patient Empowerment

Abstract

Cardiometabolic diseases, encompassing cardiovascular disease, type 2 diabetes mellitus, and metabolic syndrome, represent a growing public health crisis, particularly in the Asia-Pacific region. Rapid di-etary and lifestyle transitions have exacerbated these conditions, making them the leading cause of mortality in the region. Recognizing the urgent need for a comprehensive, patient-centered approach, the Cardiometabolic Asia Summit brought together 260 clinicians from 15 countries to discuss innovative strategies for improving disease awareness, patient education, and long-term treatment adherence. Key discussions focused on optimizing hypertension management through integrated treatment strategies, balancing glycemic control with cardiovascular risk reduction in diabetes, and leveraging real- world evidence alongside randomized controlled trials to inform clinical decision-making. Notably, a majority of clinicians endorsed single-pill combination therapies and stepwise medication regimens to enhance adherence. Additionally, digital health innovations, including AI-powered analytics and remote monitoring, emerged as pivotal tools for improving patient outcomes. This summit under-scored the importance of holistic, personalized treatment approaches and reinforced the critical role of patient empowerment in mitigating the burden of cardiometabolic diseases. By integrating traditional and emerging therapeutic strategies, the Asia-Pacific region can advance towards more effective and sustainable cardiometabolic care.